Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36226 - 36250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Icosapent	Approved Investigational Nutraceutical	PPARA	5465	upregulated	Eicosapentaenoic Acid results in increased expression of PPARA mRNA	22q13.31	A11515
Icosapent	Approved Investigational Nutraceutical	PPARD	5467	upregulated	Eicosapentaenoic Acid results in increased expression of PPARD mRNA	6p21.31	A11515
Icosapent	Approved Investigational Nutraceutical	PPARG	5468	upregulated	Eicosapentaenoic Acid results in increased expression of PPARG mRNA	3p25.2	A11515 A22496
Icosapent	Approved Investigational Nutraceutical	PPARGC1A	10891	upregulated	Eicosapentaenoic Acid results in increased expression of PPARGC1A mRNA	4p15.2	A20470
Icosapent	Approved Investigational Nutraceutical	PTGS2	5743	upregulated	Eicosapentaenoic Acid results in increased expression of PTGS2 mRNA	1q31.1	A20608
Icosapent	Approved Investigational Nutraceutical	RETN	56729	downregulated	Eicosapentaenoic Acid results in decreased expression of RETN mRNA	19p13.2	A19957
Icosapent	Approved Investigational Nutraceutical	SOD1	6647	upregulated	Eicosapentaenoic Acid results in increased expression of SOD1 mRNA	21q22.11	A11515
Icosapent	Approved Investigational Nutraceutical	SREBF1	6720	downregulated	Eicosapentaenoic Acid results in decreased expression of SREBF1 mRNA	17p11.2	A19957
Elesclomol	Investigational	BAG3	9531	upregulated	elesclomol results in increased expression of BAG3 mRNA	10q26.11	A22497
Elesclomol	Investigational	CHORDC1	26973	upregulated	elesclomol results in increased expression of CHORDC1 mRNA	11q14.3	A22497
Elesclomol	Investigational	CLK1	1195	upregulated	elesclomol results in increased expression of CLK1 mRNA	2q33.1	A22497
Elesclomol	Investigational	CRYAB	1410	upregulated	elesclomol results in increased expression of CRYAB mRNA	11q23.1	A22497
Elesclomol	Investigational	CXCL8	3576	upregulated	elesclomol results in increased expression of CXCL8 mRNA	4q13.3	A22497
Elesclomol	Investigational	DNAJB1	3337	upregulated	elesclomol results in increased expression of DNAJB1 mRNA	19p13.12	A22497
Elesclomol	Investigational	DNAJB4	11080	upregulated	elesclomol results in increased expression of DNAJB4 mRNA	1p31.1	A22497
Elesclomol	Investigational	DNAJB9	4189	upregulated	elesclomol results in increased expression of DNAJB9 mRNA	7q31.1	A22497
Elesclomol	Investigational	FTL	2512	upregulated	elesclomol results in increased expression of FTL mRNA	19q13.33	A22497
Elesclomol	Investigational	GCLM	2730	upregulated	elesclomol results in increased expression of GCLM mRNA	1p22.1	A22497
Elesclomol	Investigational	GLA	2717	upregulated	elesclomol results in increased expression of GLA mRNA	Xq22.1	A22497
Elesclomol	Investigational	HERPUD1	9709	upregulated	elesclomol results in increased expression of HERPUD1 mRNA	16q13	A22497
Elesclomol	Investigational	HMOX1	3162	upregulated	elesclomol results in increased expression of HMOX1 mRNA	22q12.3	A22497
Elesclomol	Investigational	HSPA1A	3303	upregulated	elesclomol results in increased expression of HSPA1A mRNA	6p21.33	A22497
Elesclomol	Investigational	HSPA1B	3304	upregulated	elesclomol results in increased expression of HSPA1B mRNA	6p21.33	A22497
Elesclomol	Investigational	HSPA6	3310	upregulated	elesclomol results in increased expression of HSPA6 mRNA	1q23.3	A22497
Elesclomol	Investigational	HSPH1	10808	upregulated	elesclomol results in increased expression of HSPH1 mRNA	13q12.3	A22497

Displaying entries 36226 - 36250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability